Fortrea Holdings, Inc. (FTRE)
14.88
+0.23
(+1.57%)
USD |
NASDAQ |
Feb 09, 16:00
14.94
+0.06
(+0.40%)
After-Hours: 20:00
Fortrea Holdings EPS Diluted (Quarterly) : -0.1743 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| Medpace Holdings, Inc. | 3.857 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Humana, Inc. | 1.615 |
| Merck & Co., Inc. | 1.191 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.90M |
| Revenue (Quarterly) | 701.30M |
| Total Expenses (Quarterly) | 717.20M |
| Enterprise Value | 2.431B |
| Gross Profit Margin (Quarterly) | 14.70% |
| Profit Margin (Quarterly) | -2.27% |
| Earnings Yield | -75.82% |
| Normalized Earnings Yield | -31.66 |